echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Two doses of new crown vaccine against the emergence of a mutated virus in India reduce the risk of hospitalization by 90%...

    Two doses of new crown vaccine against the emergence of a mutated virus in India reduce the risk of hospitalization by 90%...

    • Last Update: 2021-06-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the Delta (B.


    Previously, real-world data released by PHE showed that two doses of the new crown vaccine can produce a high degree of protection against the Delta variant


    This analysis is based on 14019 cases of Delta variant infection with COVID-19 symptoms discovered between April 12 and June 4 this year, of which 166 COVID-19 patients were hospitalized


    Based on these data, the researchers calculated the risk of hospitalization for patients infected with Delta variants


    Further calculated vaccine efficacy showed that for the Delta variant, one dose of BNT162b2 vaccine reduced the risk of hospitalization by 94%, and two doses of BNT162b2 reduced the risk of hospitalization by 96%


    ▲Evaluation of the protective efficacy of the new crown vaccine against hospitalizations due to Delta and Alpha mutants (picture source: reference [3])

    ▲Evaluation of the protective efficacy of the new crown vaccine against hospitalizations due to Delta and Alpha mutants (picture source: reference [3])

    Note: The original text has been deleted

    Reference materials:

    Reference materials:

    [1] Vaccines highly effective against hospitalisation from Delta variant.


    [1] Vaccines highly effective against hospitalisation from Delta variant.


    [3] Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.


    ▽ attention [drug Mingkang Germany ] micro-channel public number

    [Medical attention Mingkang Germany ] ] micro-channel public number

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.